Developmental Basis of Congenital Anomalies Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Developmental Basis of Congenital Anomalies. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Developmental Basis of Congenital Anomalies Indian Medical PG Question 1: All the following drugs are teratogenic except?
- A. Alcohol
- B. Phenytoin
- C. Warfarin
- D. Metoclopramide (Correct Answer)
Developmental Basis of Congenital Anomalies Explanation: ***Metoclopramide***
- **Metoclopramide** is an antiemetic and prokinetic agent generally considered **safe during pregnancy**.
- It does **not** have established teratogenic effects and is often used to treat **nausea and vomiting** in pregnant women.
*Alcohol*
- **Alcohol** is a well-known teratogen, leading to **fetal alcohol syndrome** characterized by facial dysmorphia, growth restriction, and CNS abnormalities.
- Even moderate consumption can have detrimental effects on fetal development, particularly brain development.
*Phenytoin*
- **Phenytoin** is an antiepileptic drug associated with **fetal hydantoin syndrome**, which includes craniofacial anomalies, mental deficits, and distal phalangeal hypoplasia.
- It interferes with **folate metabolism** and can increase the risk of neural tube defects.
*Warfarin*
- **Warfarin** is an anticoagulant that can cause **fetal warfarin syndrome** when used during the first trimester, leading to chondrodysplasia punctata, nasal hypoplasia, and skeletal abnormalities.
- Its mechanism involves interfering with **vitamin K-dependent coagulation factors**, affecting fetal bone and cartilage development.
Developmental Basis of Congenital Anomalies Indian Medical PG Question 2: Most common congenital uterine anomaly is?
- A. Bicornuate uterus
- B. Unicornuate uterus
- C. Arcuate uterus
- D. Septate uterus (Correct Answer)
Developmental Basis of Congenital Anomalies Explanation: ***Septate uterus***
- A septate uterus is the most common congenital uterine anomaly, characterized by a **fibrous or muscular septum** dividing the uterine cavity.
- This anomaly results from incomplete resorption of the **müllerian ducts** during development.
*Bicornuate uterus*
- A bicornuate uterus involves **two uterine horns** that are partially or completely separate, leading to a heart-shaped uterus.
- While relatively common, it is **less prevalent** than the septate uterus.
*Unicornuate uterus*
- A unicornuate uterus is an anomaly where only **one side of the müllerian duct develops**, resulting in a uterus with only one horn and one fallopian tube.
- This is a **rare anomaly** compared to septate and bicornuate uteri.
*Arcuate uterus*
- An arcuate uterus is considered a **mild variant of a normal uterus**, with a slight indentation in the fundus.
- It often has **no clinical significance** and is less severe than other anomalies.
Developmental Basis of Congenital Anomalies Indian Medical PG Question 3: Most important factor determining the placental transfer and effect of anesthetic agent on the fetus
- A. Protein binding (Correct Answer)
- B. MAC
- C. Route of anesthetic
- D. Duration of pregnancy
Developmental Basis of Congenital Anomalies Explanation: ***Protein binding***
- Highly **protein-bound** drugs are less likely to cross the placenta because only the **unbound fraction** is pharmacologically active and available for transfer.
- The placenta acts as a barrier, and drugs need to be in their free, unbound form to efficiently traverse biological membranes and reach the fetus.
*MAC*
- **Minimum Alveolar Concentration (MAC)** applies to inhaled anesthetics and reflects their potency for inducing anesthesia in the mother, not their placental transfer or fetal effect directly.
- While inhaled anesthetics can cross the placenta, MAC itself is not the primary determinant of the extent of transfer or fetal impact compared to protein binding.
*Route of anesthetic*
- The **route of anesthetic administration** (e.g., intravenous, inhaled) influences the drug's absorption and systemic concentration in the mother.
- However, once in maternal circulation, the ultimate factor determining placental transfer is the physicochemical properties of the drug, with protein binding being paramount.
*Duration of pregnancy*
- The **duration of pregnancy** can influence fetal development and organ maturity, which affects how the fetus metabolizes and
eliminates drugs.
- It does not, however, directly determine the initial *transfer* of the anesthetic agent across the placenta; that is governed by drug properties.
Developmental Basis of Congenital Anomalies Indian Medical PG Question 4: Which of the following anti-epileptic drugs has the highest teratogenic potential?
- A. Carbamazepine
- B. Phenytoin
- C. Valproate (Correct Answer)
- D. Lamotrigine
Developmental Basis of Congenital Anomalies Explanation: ***Correct: Valproate***
- **Valproate has the highest teratogenic potential** among all anti-epileptic drugs, with a **10-20% risk of major congenital malformations**
- **Neural tube defects** (spina bifida) occur in **1-2% of exposed pregnancies**, which is 10-20 times higher than the general population
- Other significant risks include **cardiac malformations, craniofacial abnormalities**, and **neurodevelopmental disorders** (autism spectrum disorder, reduced IQ)
- **Fetal valproate syndrome** is a recognized clinical entity
- Current guidelines strongly recommend **avoiding valproate in women of childbearing potential** unless no alternatives exist
*Incorrect: Carbamazepine*
- Has teratogenic risks but significantly **lower than valproate** (2-5% risk of major malformations)
- Associated with **neural tube defects** (0.5-1% risk, lower than valproate)
- Considered a safer alternative when valproate must be avoided
*Incorrect: Phenytoin*
- Causes **fetal hydantoin syndrome** with characteristic features: craniofacial anomalies, nail/digital hypoplasia, growth restriction, and developmental delay
- Teratogenic risk is **moderate** (approximately 5-10% risk of major malformations)
- Risk is significant but **lower than valproate**
*Incorrect: Lamotrigine*
- Considered **one of the safest anti-epileptic drugs** during pregnancy
- Low teratogenic risk with **major malformation rate of 2-3%** (close to baseline population risk)
- Slight increased risk of **oral clefts** at higher doses
- **Preferred choice** for women of childbearing potential requiring anti-epileptic therapy
Developmental Basis of Congenital Anomalies Indian Medical PG Question 5: Which of the following drugs is given during pregnancy, resulting in fetal abnormalities such as cleft lip and central nervous system defects?
- A. Warfarin
- B. Phenytoin
- C. Valproic acid
- D. Retinoic acid (Vitamin A derivative) (Correct Answer)
Developmental Basis of Congenital Anomalies Explanation: ***Retinoic acid (Vitamin A derivative)***
- **Retinoic acid** (including isotretinoin) is a **potent teratogen** with a characteristic pattern of malformations including **craniofacial defects (cleft lip/palate)**, **cardiac abnormalities** (transposition of great arteries, VSD), and **severe CNS defects** (hydrocephalus, microcephaly, neural tube defects)
- The mechanism involves **disruption of gene expression** during embryogenesis, particularly affecting **neural crest cell migration** critical for facial and cardiac development
- The combination of **cleft lip + CNS defects** is characteristic of retinoic acid embryopathy, making it the most fitting answer
*Phenytoin*
- **Phenytoin** causes **fetal hydantoin syndrome** with craniofacial anomalies (cleft lip/palate in ~5-10% of cases), **hypoplastic nails and distal phalanges**, wide-set eyes, and mild developmental delays
- While cleft lip can occur, the overall pattern emphasizes **digital/nail hypoplasia** and milder CNS effects compared to retinoic acid
*Valproic acid*
- **Valproic acid** is primarily associated with **neural tube defects** (spina bifida in 1-2% of exposures), the hallmark of valproate embryopathy
- Can cause minor facial anomalies and cardiac defects, but the **characteristic feature is spina bifida**, not cleft lip
*Warfarin*
- **Warfarin** causes **fetal warfarin syndrome** with distinctive features: **nasal hypoplasia**, **stippled epiphyses** (chondrodysplasia punctata), and potential CNS defects from hemorrhage
- Does **not** typically cause cleft lip; the skeletal abnormalities are the defining feature
Developmental Basis of Congenital Anomalies Indian Medical PG Question 6: In pregnancy, neural tube defects arise in the fetus due to a deficiency of which specific vitamin in the mother?
- A. Folic Acid (Correct Answer)
- B. Vitamin A
- C. Vitamin C
- D. Vitamin D
Developmental Basis of Congenital Anomalies Explanation: ***Folic Acid***
- Deficiency of **folic acid (Vitamin B9)** during early pregnancy is a well-established cause of **neural tube defects (NTDs)** in the fetus.
- Adequate folate intake is crucial for proper **neural tube closure**, which occurs at 3-4 weeks gestation.
*Vitamin D*
- **Vitamin D deficiency** is linked to bone health issues, such as **rickets** in children and **osteomalacia** in adults, and can impact immune function.
- It is not directly associated with the development of **neural tube defects**.
*Vitamin A*
- **Vitamin A** is essential for vision, immune function, and cell growth, but both its **deficiency** and **excess** can cause birth defects.
- Excessive intake of preformed Vitamin A (retinol) is **teratogenic** (e.g., causing craniofacial, cardiac, and central nervous system anomalies), but deficiency does not typically cause neural tube defects.
*Vitamin C*
- **Vitamin C** is vital for collagen synthesis, wound healing, and acts as an antioxidant.
- Its deficiency causes **scurvy**, characterized by weakened connective tissue, but is not implicated in neural tube defects.
Developmental Basis of Congenital Anomalies Indian Medical PG Question 7: What maternal condition is commonly associated with congenital heart defects in the fetus?
- A. ACE inhibitor
- B. GDM
- C. Pregestational DM (Correct Answer)
- D. Valproate
Developmental Basis of Congenital Anomalies Explanation: ***Pregestational DM***
- **Pre-existing diabetes** in the mother is a significant risk factor for various **congenital anomalies**, including **congenital heart defects**, due to suboptimal glycemic control during early embryogenesis.
- Poorly controlled **maternal hyperglycemia** leads to increased oxidative stress and altered cellular metabolism in the developing fetus, impacting cardiovascular development.
*ACE inhibitor*
- **ACE inhibitors** are teratogenic, primarily causing **renal dysfunction** (e.g., renal tubular dysplasia, oligohydramnios, anuria) and **fetal growth restriction**, especially when used in the second and third trimesters.
- While they can have adverse fetal effects, their association with **congenital heart defects** is less pronounced compared to other teratogenic exposures.
*GDM*
- **Gestational diabetes mellitus (GDM)** typically develops in the second or third trimester when major organogenesis is complete, making its association with **structural congenital anomalies**, including heart defects, significantly lower than pregestational diabetes.
- GDM is more commonly associated with fetal **macrosomia**, **hypoglycemia**, and respiratory distress syndrome at birth.
*Valproate*
- **Valproate** is a known teratogen associated with a specific pattern of anomalies, most notably **neural tube defects** (e.g., spina bifida), and facial dysmorphisms.
- While it can be associated with an increased risk of some congenital heart defects, its primary and most significant fetal risk is **neural tube defects**.
Developmental Basis of Congenital Anomalies Indian Medical PG Question 8: 18 weeks pregnant female presents with no high risk of NTD and low risk of trisomy 21 on quad test. What is the most appropriate next step in management?
- A. Repeat non-invasive screening test.
- B. Perform invasive diagnostic testing.
- C. Perform amniotic fluid analysis.
- D. Perform a detailed fetal ultrasound. (Correct Answer)
Developmental Basis of Congenital Anomalies Explanation: ***Perform a detailed fetal ultrasound.***
- A **detailed fetal ultrasound** (often referred to as an **anatomy scan**) at around 18-22 weeks is a standard component of prenatal care for all pregnant women, regardless of screening test results.
- This ultrasound evaluates fetal anatomy for structural anomalies, assesses fetal growth, and confirms gestational age, providing crucial information even with low-risk screening.
*Repeat non-invasive screening test.*
- Repeating a non-invasive screening test (like another quad screen or NIPT) is generally **not indicated** when initial results show a low risk and there are no other clinical concerns.
- Such tests are primarily for screening purposes, and a second low-risk result would offer little additional actionable information, as their positive predictive value is low.
*Perform invasive diagnostic testing.*
- **Invasive diagnostic testing**, such as **amniocentesis** or **chorionic villus sampling (CVS)**, carries a risk of miscarriage and is reserved for situations with a high risk of chromosomal abnormalities or genetic conditions.
- Given the low-risk quad screen results for trisomy 21 and no high risk for NTDs, invasive testing is **not warranted** at this stage.
*Perform amniotic fluid analysis.*
- **Amniotic fluid analysis** is part of an amniocentesis, an **invasive diagnostic procedure** designed to detect chromosomal abnormalities or genetic disorders.
- This procedure is typically reserved for cases where screening tests indicate a high risk or there is a clinical suspicion of a genetic condition; it's **not a routine step** after a low-risk quad screen.
Developmental Basis of Congenital Anomalies Indian Medical PG Question 9: The labia majora develop from which embryological structure?
- A. Urogenital folds
- B. Labioscrotal swellings (Correct Answer)
- C. Müllerian ducts
- D. Genital tubercle
Developmental Basis of Congenital Anomalies Explanation: ***Labioscrotal swellings***
- The **labia majora** develop from the **labioscrotal swellings**, which are paired bilateral structures that appear around week 9-10 of development [1].
- These swellings arise lateral to the urogenital folds and do not fuse in females, forming the labia majora.
- In males, these same structures fuse in the midline to form the scrotum.
- This is a key example of **sexual differentiation** in embryological development [1].
*Urogenital folds*
- The urogenital folds form the **labia minora** in females, not the labia majora.
- In males, these folds fuse to form the ventral aspect of the penis and enclose the penile urethra.
*Genital tubercle*
- The genital tubercle forms the **clitoris** in females and the **glans penis** in males.
- It does not contribute to the formation of the labia majora.
*Müllerian ducts*
- The Müllerian (paramesonephric) ducts form the **upper vagina, uterus, and fallopian tubes** in females.
- They are internal structures and do not contribute to external genitalia like the labia majora.
Developmental Basis of Congenital Anomalies Indian Medical PG Question 10: During embryological development, failure of the urorectal septum to completely separate the cloaca results in which of the following congenital anomalies?
- A. Imperforate anus
- B. Cloacal exstrophy
- C. Rectovaginal fistula
- D. Persistent cloaca (Correct Answer)
Developmental Basis of Congenital Anomalies Explanation: During embryological development, failure of the urorectal septum to completely separate the cloaca results in which of the following congenital anomalies?
***Persistent cloaca***
- This condition occurs when the **urorectal septum** fails to fully descend and partition the cloaca into the urogenital sinus anteriorly and the anorectal canal posteriorly [1].
- As a result, the rectum, vagina, and urinary tract all drain into a **single common channel**, leading to various functional and anatomical complications [1].
*Imperforate anus*
- This anomaly involves the **absence or abnormal closure of the anal opening**, but it does not typically involve a shared channel with the urinary or reproductive tracts.
- It arises from abnormal development of the **hindgut's caudal portion** or failure of the anal membrane to rupture.
*Cloacal exstrophy*
- This is a more complex and severe malformation characterized by the **exposure of the bladder, bowel, and sometimes genitalia** to the outside of the body.
- While it involves cloacal derivatives, it's primarily a defect in the **closure of the ventral body wall** and does not directly result from incomplete septation in the same manner as a persistent cloaca.
*Rectovaginal fistula*
- This is an **abnormal connection between the rectum and the vagina**. While it involves a communication between two distinct structures, it is a localized defect.
- It typically arises from **incomplete separation of the rectum and vagina**, which can be a consequence of less severe septation defects, but it is not the complete persistence of a single common channel like persistent cloaca.
More Developmental Basis of Congenital Anomalies Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
